News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
195,857 Results
Type
Article (4446)
Company Profile (30)
Press Release (191381)
Multimedia
Podcasts (4)
Webinars (1)
Section
Business (74440)
Career Advice (85)
Deals (12441)
Drug Delivery (10)
Drug Development (22899)
Employer Resources (9)
FDA (3990)
Job Trends (4421)
News (111602)
Policy (7591)
Tag
2027 Pharm Country Standard (1)
Academia (375)
Academic (1)
Accelerated approval (12)
Adcomms (3)
Allergies (67)
Alliances (8878)
ALS (56)
Alzheimer's disease (508)
Antibody-drug conjugate (ADC) (137)
Approvals (4302)
Artificial intelligence (125)
Autoimmune disease (94)
Automation (15)
Bankruptcy (100)
Best Places to Work (4023)
Biosimilars (47)
Biotechnology (17)
Bladder cancer (79)
Brain cancer (17)
Breast cancer (316)
Cancer (2193)
Cardiovascular disease (177)
Career advice (73)
Career pathing (5)
CAR-T (79)
CDC (3)
Cell therapy (205)
Cervical cancer (15)
Clinical research (22008)
Collaboration (499)
Company closure (2)
Compensation (402)
Complete response letters (18)
COVID-19 (569)
CRISPR (33)
C-suite (311)
Cystic fibrosis (43)
Data (3507)
Depression (62)
Dermatology (30)
Diabetes (204)
Diagnostics (1977)
Digital health (16)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (54)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (90)
Earnings (60937)
Editorial (5)
Employer branding (1)
Employer resources (7)
Events (27449)
Executive appointments (250)
FDA (5552)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (3)
Frontotemporal dementia (12)
Funding (400)
Gene editing (69)
Generative AI (6)
Gene therapy (202)
GLP-1 (258)
Government (708)
Grass and pollen (1)
Guidances (349)
Healthcare (5100)
HIV (35)
Huntington's disease (7)
IgA nephropathy (38)
Immunology and inflammation (87)
Immuno-oncology (21)
Indications (69)
Infectious disease (669)
Inflammatory bowel disease (85)
Inflation Reduction Act (2)
Influenza (48)
Intellectual property (119)
Interviews (12)
IPO (7691)
IRA (4)
Job creations (615)
Job search strategy (63)
JPM (8)
Kidney cancer (10)
Labor market (22)
Layoffs (127)
Leadership (1)
Legal (1484)
Liver cancer (31)
Longevity (4)
Lung cancer (320)
Lymphoma (199)
Machine learning (12)
Management (2)
Manufacturing (209)
MASH (102)
Medical device (4266)
Medtech (4295)
Mergers & acquisitions (5254)
Metabolic disorders (470)
mRNA (21)
Multiple sclerosis (88)
NASH (8)
Neurodegenerative disease (136)
Neuropsychiatric disorders (37)
Neuroscience (1015)
NextGen: Class of 2026 (1239)
Non-profit (670)
Now hiring (7)
Obesity (143)
Opinion (25)
Ovarian cancer (80)
Pain (82)
Pancreatic cancer (101)
Parkinson's disease (118)
Partnered (3)
Patents (210)
Patient recruitment (226)
Peanut (29)
People (9654)
Pharmaceutical (5)
Pharmacy benefit managers (4)
Phase 1 (6016)
Phase 2 (9330)
Phase 3 (8526)
Pipeline (3988)
Policy (26)
Postmarket research (699)
Preclinical (1988)
Press Release (21)
Prostate cancer (115)
Psychedelics (1)
Radiopharmaceuticals (69)
Rare diseases (322)
Real estate (829)
Recruiting (5)
Regulatory (7164)
Reports (14)
Research institute (318)
Resumes & cover letters (9)
Rett syndrome (25)
RNA editing (3)
RSV (30)
Schizophrenia (80)
Series A (43)
Series B (45)
Service/supplier (1)
Sickle cell disease (48)
Special edition (7)
Spinal muscular atrophy (52)
Sponsored (3)
Startups (396)
Stomach cancer (4)
Supply chain (19)
Tariffs (5)
The Weekly (4)
Vaccines (280)
Venture capital (16)
Weight loss (96)
Women's health (34)
Worklife (4)
Date
Today (3)
Last 7 days (337)
Last 30 days (1141)
Last 365 days (14658)
2026 (2831)
2025 (14732)
2024 (12433)
2023 (14249)
2022 (15023)
2021 (15442)
2020 (14629)
2019 (11550)
2018 (8554)
2017 (9850)
2016 (7839)
2015 (9571)
2014 (7178)
2013 (5390)
2012 (5767)
2011 (6151)
2010 (5754)
Location
Africa (105)
Alabama (47)
Arizona (94)
Arkansas (2)
Asia (11023)
Australia (1205)
California (5186)
Canada (1309)
China (387)
Colorado (232)
Connecticut (252)
Delaware (154)
Europe (25643)
Florida (803)
Georgia (214)
Hawaii (1)
Idaho (14)
Illinois (301)
India (18)
Indiana (363)
Iowa (10)
Japan (233)
Kansas (40)
Kentucky (14)
Louisiana (11)
Maine (50)
Maryland (642)
Massachusetts (3682)
Michigan (132)
Minnesota (265)
Missouri (70)
Montana (11)
Nebraska (3)
Nevada (66)
New Hampshire (29)
New Jersey (1791)
New Mexico (3)
New York (1426)
North Carolina (647)
North Dakota (1)
Northern California (2603)
Ohio (102)
Oregon (10)
Pennsylvania (1092)
Puerto Rico (9)
Rhode Island (10)
South America (202)
South Carolina (33)
Southern California (2159)
Tennessee (70)
Texas (993)
United States (18980)
Utah (147)
Virginia (123)
Washington D.C. (22)
Washington State (409)
Wisconsin (23)
Wyoming (1)
195,857 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Preliminary results for the year ended 31 December 2025
March 26, 2026
·
94 min read
Press Releases
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
April 1, 2026
·
10 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2026
March 18, 2026
·
2 min read
Press Releases
Positive VAX-31 Phase 1/2 Adult Data Published in The Lancet Infectious Diseases Highlight Best-in-Class Potential of Vaxcyte’s 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate
March 19, 2026
·
12 min read
Press Releases
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
March 26, 2026
·
13 min read
Press Releases
NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st
March 25, 2026
·
1 min read
Press Releases
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
March 27, 2026
·
2 min read
Press Releases
Faron’s Financial Statements Release 1 January to 31 December 2025
March 4, 2026
·
32 min read
Press Releases
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 31, 2026
April 1, 2026
·
2 min read
Press Releases
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025
March 5, 2026
·
8 min read
1 of 19,586
Next
